Lv51
950 积分 2023-12-13 加入
GLP-1 Receptor Agonists
9小时前
已完结
Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced ALK -Rearranged Squamous and Adenosquamous Non–Small Cell Lung Cancers
11小时前
求助中
Impact of adding hormone therapy to postoperative radiotherapy in prostate cancer
6天前
已完结
Reconsidering adjuvant and perioperative immune-checkpoint inhibition: de-escalation, expansion and personalization
15天前
已完结
Heads or the Tail?
23天前
已完结
Neoadjuvant pamiparib plus abiraterone and androgen deprivation therapy for high-risk/very high-risk localized prostate cancer: an open-label, single-arm, phase 2 study
27天前
已完结
【仅需补充资料，谢谢 】Neoadjuvant darolutamide plus androgen deprivation therapy for high-risk and locally advanced prostate cancer: a multicenter, open-label, single-arm, phase II trial
27天前
已完结
Neoadjuvant Systemic Therapy in High-risk Localised Prostate Cancer: Current Evidence and Future Directions
27天前
已完结
Prostate Cancer: A Review
27天前
已完结
Optimizing oncological and functional outcomes with wide resection techniques in robot-assisted radical prostatectomy for very high-risk prostate cancer: A single-institution retrospective study
28天前
已完结
皖公网安备34019202002308
